Legis Daily

Protecting Cures Act of 2020

USA116th CongressHR-6417| House 
| Updated: 3/31/2020
Janice D. Schakowsky

Janice D. Schakowsky

Democratic Representative

Illinois

Cosponsors (22)
Jared Huffman (Democratic)Mark Pocan (Democratic)David N. Cicilline (Democratic)David J. Trone (Democratic)Jackie Speier (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Steve Cohen (Democratic)Suzan K. DelBene (Democratic)André Carson (Democratic)Jahana Hayes (Democratic)Jerrold Nadler (Democratic)Eleanor Holmes Norton (Democratic)Bonnie Watson Coleman (Democratic)Jamie Raskin (Democratic)Lois Frankel (Democratic)Diana DeGette (Democratic)James P. McGovern (Democratic)Peter Welch (Democratic)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Protecting Cures Act of 2020 This bill prohibits the Department of Health and Human Services from withholding funding, because of ethical considerations, for research activities that use human fetal tissue, provided that the research activities have been recommended for approval by an institutional review board and otherwise comply with existing laws concerning human fetal tissue. The bill also establishes that this research is not unethical by deeming the 1988 report of the Human Fetal Tissue Transplantation Research Panel as meeting relevant statutory requirements with respect to approving the ethical status of such research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 31, 2020
Introduced in House
Mar 31, 2020
Referred to the House Committee on Energy and Commerce.
  • March 31, 2020
    Introduced in House


  • March 31, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Cell biology and embryologyMedical ethicsMedical researchOrgan and tissue donation and transplantationResearch administration and funding

Protecting Cures Act of 2020

USA116th CongressHR-6417| House 
| Updated: 3/31/2020
Protecting Cures Act of 2020 This bill prohibits the Department of Health and Human Services from withholding funding, because of ethical considerations, for research activities that use human fetal tissue, provided that the research activities have been recommended for approval by an institutional review board and otherwise comply with existing laws concerning human fetal tissue. The bill also establishes that this research is not unethical by deeming the 1988 report of the Human Fetal Tissue Transplantation Research Panel as meeting relevant statutory requirements with respect to approving the ethical status of such research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 31, 2020
Introduced in House
Mar 31, 2020
Referred to the House Committee on Energy and Commerce.
  • March 31, 2020
    Introduced in House


  • March 31, 2020
    Referred to the House Committee on Energy and Commerce.
Janice D. Schakowsky

Janice D. Schakowsky

Democratic Representative

Illinois

Cosponsors (22)
Jared Huffman (Democratic)Mark Pocan (Democratic)David N. Cicilline (Democratic)David J. Trone (Democratic)Jackie Speier (Democratic)Sheila Jackson Lee (Democratic)Debra A. Haaland (Democratic)Steve Cohen (Democratic)Suzan K. DelBene (Democratic)André Carson (Democratic)Jahana Hayes (Democratic)Jerrold Nadler (Democratic)Eleanor Holmes Norton (Democratic)Bonnie Watson Coleman (Democratic)Jamie Raskin (Democratic)Lois Frankel (Democratic)Diana DeGette (Democratic)James P. McGovern (Democratic)Peter Welch (Democratic)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cell biology and embryologyMedical ethicsMedical researchOrgan and tissue donation and transplantationResearch administration and funding